Skip to content
Tech News
clear
Topics: Today This Week This Month This Year

Belkin launches semi-solid-state power banks claiming 3x longer lifespan

Belkin has released two new power banks built with semi-solid-state battery technology it calls BoostSolid Cell, joining rivals like BMX, Kuxiu, and Zens in adopting the format. The lineup includes a $69.99 magnetic 5,000mAh Qi2 model with 15W wireless charging and a $89.99 10,000mAh unit with a display supporting up to 60W across multiple ports.

Philips Hue adds natural-language automation builder to its app

Philips Hue is rolling out Custom AI Behaviors, a feature letting users describe desired lighting automations in plain language instead of manually configuring rules. Announced at IFA alongside a new Sonos speaker integration for Hue switches, both updates arrive via a software update in November. The AI feature requires the Hue Bridge Pro's processing power to run.

Anker's new Soundcore Sleep Earbuds 4 Pro adds a screen to its charging case

Anker unveiled the Soundcore Sleep Earbuds 4 and 4 Pro, successors to last year's A30 sleepbuds aimed at side-sleepers. Both models shrink the contact area for comfort, add Bluetooth 6.0, longer battery life and stronger noise masking, while the Pro version's SleepHub case includes an OLED display and phone-free controls plus an in-ear PPG sensor for tracking heart rate and sleep stress.

Anker unveils first OTC hearing aids at IFA 2026

Anker used IFA 2026 to reveal its first over-the-counter hearing aids, a receiver-in-canal design built on the company's Thus audio chip previously used in its Soundcore earbuds. The devices use four beam-forming microphones to isolate speech from a person facing the wearer, offer up to 12 hours of battery life (36 with the charging case), and can gain two hours of use from a five-minute fast charge. Anker has not yet disclosed specific models, US pricing, or availability, saying more details will come later this year.

Soundcore expands Thus call-quality chip to Space 2 Pro headphones and new earbuds

At IFA 2026, Soundcore unveiled the Space 2 Pro headphones alongside AeroClip 2, AeroClip 2 Pro, and Liberty Buds 2, all built around its Thus audio processing chip first launched in April. The Space 2 Pro uses a 6-microphone array for voice isolation and eight microphones for adaptive noise cancellation claimed to be 1.5 times stronger than its predecessor, while offering up to 60 hours of battery life and high-res LDAC audio support. The headphones launch September 22 for $200 in the US, EU, and UK, with the AeroClip 2 arriving the same day at $170.

November 2025 Solar Storm Threw US GPS Signals Off by Up to 33 Feet

Scientists led by Endawoke Yizengaw at The Aerospace Corporation analyzed data from the intense November 2025 solar storm and found unprecedented, coast-to-coast atmospheric disturbances across the continental United States. These disturbances pushed GPS positioning errors past 10 meters in some regions, a scale of disruption not previously documented.

Google launches Gemini 3.8 Flash and a cybersecurity-focused Flash Cyber variant

Google released two new AI models on Wednesday: a standard Gemini 3.8 Flash built for agentic tasks, coding, and multi-step reasoning, and Flash Cyber, tuned specifically for finding and fixing software vulnerabilities. CEO Sundar Pichai said 3.8 Flash beats many larger frontier models on the DeepSWE coding benchmark at lower cost, while Flash Cyber scored 86.2% on the CyberGym benchmark and found vulnerabilities across 20 programming languages with over 70% success in internal testing.

Psilocybin prevents chemotherapy-induced nerve damage in mouse study

Researchers at MD Anderson Cancer Center found that two doses of psilocybin, the psychoactive compound in magic mushrooms, given before chemotherapy completely prevented mice from developing neuropathy, a painful nerve condition affecting up to 60% of patients on platinum-based cancer drugs. The findings, published in Science, suggest the compound protects sensory nerve endings from the energy depletion that chemotherapy drugs typically cause.

In vivo CAR-T therapy shows early promise for multiple sclerosis in small trial

A phase of clinical testing involving sixteen patients with multiple sclerosis and related autoimmune disorders showed symptom improvement after researchers used a modified virus to instruct T cells inside the body to produce chimeric antigen receptors, targeting the B cells responsible for autoimmune attacks. The findings, published this week in The New England Journal of Medicine, mark one of the first demonstrations that CAR-T therapy can be generated directly inside a patient rather than engineered in a lab and reinfused.

Today's top topics: openai google android authority anthropic elon musk nvidia apple pentagon ai agents techcrunch disrupt 2026
Browse all topics →  ·  Today's trending topics →